Melatonin in the saliva of adolescent girls with polycystic ovary syndrome

Authors

DOI:

https://doi.org/10.22141/2224-0721.18.2.2022.1154

Keywords:

adolescent girls, polycystic ovary syndrome, melatonin

Abstract

Background. The formation of polycystic ovary syndrome (PCOS) and the manifestation of its clinical manifestations often begin in adolescence. In recent years, one of the new and modern areas in the study of reproductive dysfunction is the problem of melatonin on the gonadotropic function of the pituitary gland (ovariogenesis). The purpose of the study was to determine the level of melatonin in the saliva of adolescent girls with PCOS. Materials and methods. A single-center prospective simple randomi­zed study was conducted with 23 patients aged 14–18 years (inclusive) with PCOS. The control group consisted of 25 girls of the same age without gynecological status violations. Determination of melatonin levels in saliva was performed by high performance liquid chromatography with tandem mass spectrometry (HPLC-MS). Before salivation during the day and throughout the saliva collection period, patients excluded caffeine, alcohol, and exercise, did not smoke for one hour before collection, did not brush their teeth, did not floss, rinsed their mouths, and did not chew gum. Results. There were no significant differences in the age of the girls in the main group and the comparison group (16.70 ± 0.11 years in the main group and 16.90 ± 0.14 years in the comparison group, p > 0.05). The most common symptoms of PCOS in girls were: hypomenstrual syndrome (86.9 %), dermopathy (82.6 %) and hirsutism (60.8 %). Girls with PCOS had significantly higher melatonin levels in saliva (03:00) (28.89 [18.17; 46.53] pg/ml) compared to girls in the comparison group (12.07 [11.56; 16.27] pg/ml, p < 0.01). A pro­bable difference in melatonin levels in saliva depending on age has not been established. Conclusions. The results of the study indicate a violation of hormonal balance in polycystic ovary syndrome, in particular an increase in melatonin levels, which indicates the need to determine it in the process of diagnosis and treatment.

Downloads

Download data is not yet available.

References

Semenyna HB, Pankiv VІ, Pashkovska NV, Korytko OO, Pankiv IV. Ovarial factors in the pathogenesis of chronic anovulation in polycystic ovary syndrome. Problems of Endocrine Pathology. 2021;71(1):65-71. doi: 10.21856/j-PEP.2020.1.09.

Sadeeqa S, Mustafa T, Latif S. Polycystic Ovarian Syndrome-Related Depression in Adolescent Girls: A Review. J Pharm Bioallied Sci. 2018 Apr-Jun;10(2):55-59. doi: 10.4103/JPBS.JPBS_1_18.

Semeniuk LM, Yuzvenko TYu, Larina OV. Features of carbohydrate metabolism in women of early reproductive age with polycystic ovary syndrome. International Journal of Endocrinology (Ukraine). 2018;14(3):229-234. doi: 10.22141/2224-0721.14.3.2018.136417. (in Ukrainian).

Uk A, Decanter C, Grysole C, et al. Polycystic ovary syndrome phenotype does not have impact on oocyte morphology. Reprod Biol Endocrinol. 2022 Jan 5;20(1):7. doi: 10.1186/s12958-021-00874-2.

Shi B, Feng D, Sagnelli M, Jiao J, Sun X, Wang X, Li D. Fructose levels are elevated in women with polycystic ovary syndrome with obesity and hyperinsulinemia. Hum Reprod. 2020 Jan 1;35(1):187-194. doi: 10.1093/humrep/dez239.

Wawrzkiewicz-Jałowiecka A, Kowalczyk K, Trybek P, et al. In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. Int J Mol Sci. 2020 Sep 25;21(19):7054. doi: 10.3390/ijms21197054.

Yu K, Wang RX, Li MH, et al. Melatonin Reduces Androgen Production and Upregulates Heme Oxygenase-1 Expression in Granulosa Cells from PCOS Patients with Hypoestrogenia and Hyperandrogenia. Oxid Med Cell Longev. 2019 Oct 20;2019:8218650. doi: 10.1155/2019/8218650.

Danilova MV, Usoltseva EN. Significance of the pineal gland hormone melatonin in maintaining the health of women of reproductive age (a review). Obstetrics, gynecology and reproduction. 2019;4:337-334. doi: 10.17749/2313-7347.2019.13.4.337-344. (in Russian).

Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472-479. doi: 10.20945/2359-3997000000066.

Al-Omary FA. Melatonin: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2013;38:159-226. doi: 10.1016/B978-0-12-407691-4.00005-8.

Mojaverrostami S, Asghari N, Khamisabadi M, Heidari Khoei H. The role of melatonin in polycystic ovary syndrome: A review. Int J Reprod Biomed. 2019;17(12):865-882. doi:10.18502/ijrm.v17i12.5789.

Andreeva EN, Absatarova YuS, Sheremetyeva EV. Analysis of the informativeness of melatonin evaluation in polycystic ovary syndrome. Obesity and Metabolism. 2016;13(4):15-20. doi: 10.14341/OMET2016415-20.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 Jan;81(1):19-25. doi: 10.1016/j.fertnstert.2003.10.004.

Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril. 2006 Jul;86 Suppl 1:S6. doi: 10.1016/j.fertnstert.2006.04.015.

Yi S, Xu J, Shi H, Li W, Li Q, Sun YP. Association between melatonin receptor gene polymorphisms and polycystic ovarian syndrome: a systematic review and meta-analysis. Biosci Rep. 2020;40(6):BSR20200824. doi:10.1042/BSR20200824.

Kandemir YB, Konuk E, Katırcı E, Xxx F, Behram M. Is the effect of melatonin on vascular endothelial growth factor receptor-2 associated with angiogenesis in the rat ovary? Clinics (Sao Paulo). 2019;74:e658. doi:10.6061/clinics/2019/e658.

Xu XL, Deng SL, Lian ZX, Yu K. Estrogen Receptors in Polycystic Ovary Syndrome. Cells. 2021;10(2):459. doi:10.3390/cells10020459.

Liu Y, Yu Z, Zhao S. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. J Assist Reprod Genet. 2021;38(2):471-477. doi:10.1007/s10815-020-02014-y.

Shen M, Cao Y, Jiang Y, Wei Y, Liu H. Melatonin protects mouse granulosa cells against oxidative damage by inhibiting FOXO1-mediated autophagy: Implication of an antioxidation-independent mechanism. Redox Biol. 2018;18:138-157. doi:10.1016/j.redox.2018.07.004.

Ryu Y, Kim SW, Kim YY, Ku SY. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. Int J Mol Sci. 2019;20(11):2720. doi:10.3390/ijms20112720.

Hatırnaz Ş, Ata B, Hatırnaz ES, et al. Oocyte in vitro maturation: A sytematic review. Turk J Obstet Gynecol. 2018;15(2):112-125. doi:10.4274/tjod.23911.

Published

2022-04-22

How to Cite

Sorokman, T., Makarova, O., & Ostapchuk, V. (2022). Melatonin in the saliva of adolescent girls with polycystic ovary syndrome. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 18(2), 100–103. https://doi.org/10.22141/2224-0721.18.2.2022.1154

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 3 > >>